Geron Corporation

FDA approves embryonic stem cells for use in study of spinal cord injury

posted on February 20, 2009 - 5:45pm
The U.S. Food and Drug Administration (FDA) has said yes to a small safety trial of nervous-system stem cells in people with recently sustained injuries to the middle (thoracic) part of the spinal cord, the biopharmaceutical company Geron Corporation of Menlo Park, Calif., announced Jan. 23, 2009.

New content is being added every day. Please check back again.